Deric Park, MD, discusses a phase 1/2 study of IGV-001, a novel treatment for glioblastoma.
Deric Park, MD
Advertisement
Deric Park, MD, is a neuro-oncologist at John Theurer Cancer Center, Hackensack University Medical Center, in Hackensack, NJ.
Articles by Deric Park, MD
Deric Park, MD, discusses what challenges remain in treating glioblastoma, as well as new avenues for research in this difficult disease.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
